Jump to contentAllNewsSportCultureLifestyleThe Shingrix shingles vaccine could significantly lower the risk of stroke, heart failure, and heart disease. (PA Wire)Research from the University of Oxford indicates that the Shingrix shingles vaccine could significantly lower the risk of stroke, heart failure, and heart disease. A study of over 70,000 adults aged over 60 found Shingrix recipients lived up to 12 per cent longer without heart failure compared to those given the older Zostavax jab. Lead researcher Dr Maxime Taquet estimated that vaccinating everyone over 60 in the UK with Shingrix could prevent tens of thousands of deaths over seven years. Scientists believe the vaccine protects the heart either by suppressing the herpes zoster virus or via cardiac benefits from ingredients in the jab. The findings published in Nature Medicine follow previous research that linked the Shingrix immunisation to a 17 per cent reduction in dementia diagnoses. In fullNHS shingles jab could lower risk of stroke and heart attacks, study findsMore bulletinsThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in

Large study finds that people who received the ‘recombinant’ vaccine for the viral condition had a lower risk of cardiovascular problems.

Oxford researchers call shingles shot first vaccine protecting both heart and brain. Lower heart disease risk follows study showing reduced dementia risk.